We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2016 16:59 | As on Twitter. We can quantify muscle fiber regeneration in a fully automated way and hope to reduce this in #Duchenne with ezutromid #ADConf16 | infocusint | |
12/11/2016 19:13 | Lot's of summit twitter activity today re AD conf 2016 | waterloo01 | |
12/11/2016 12:29 | Thanks Waterloo. Great to hear such calm and reasoned confidence from John Tinsley. | solomon | |
12/11/2016 11:29 | RDZ from 171. John Tinsley | waterloo01 | |
11/11/2016 20:20 | Should have a positive read through for both us and SRPT. Regulators on both sides of th pond, continue to say, just show us some potential efficacy and we'll approve. | waterloo01 | |
11/11/2016 14:25 | Trump is way more dangerous than Le Pen in my view, and very worrying if he gets Steve Bannon as Chief of Staff who is known as the most dangerous political operative in the US, have a look at his Breitbart News, not good. | jag63 | |
11/11/2016 13:03 | PTC news,translarna tests renewed.shares rising pre market | joe shone | |
11/11/2016 12:09 | O/T Take a look at the second bullet point, waterloo01. It's clear what 'from conception ' implies. | freedosh | |
11/11/2016 11:59 | O/T At least he's not an idealog but a deal maker and the constitution will hold back some of the excesses. Much more worried about Le Pen! | waterloo01 | |
11/11/2016 11:55 | Sorry about kicking off the dottiness - I deleted a rant against Trump who, for me at least, has made America grate again. www.grateagain@Trump | freedosh | |
10/11/2016 20:23 | Just red herrings. Trump transition positions re health. Note FDA. Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products | waterloo01 | |
10/11/2016 09:22 | Good on you. No idea why we went the opposite way to the rest of biotech yesterday. Hopefully an update on recruitment soon and RDZ next steps. | waterloo01 | |
10/11/2016 09:14 | Just bought 12,000 shares at 180, not showing | sorrento06 | |
09/11/2016 20:58 | I wonder why Zacks have little support for Summit? Perhaps they have someone with hidden agenda? They've certainly been out of line with many other commentators for some time and don't seem to have their finger on the pulse. | hugus maximus | |
09/11/2016 18:05 | Hi H-M, yes massive potential but I thought a 20x uptick would be a good start to wish for :-) We could also start adding in the C.Diff potential too but let's not get carried away :-) | freemoney1 | |
09/11/2016 17:48 | Evening FM ... and the value of Sarepta's Market Cap is based on their DMD drug having the ability (if it ever actually works)of treating 13% of the boys. And although a little premature at this stage, Ezutromid's science could well work with Beckers Duchenne which is approximately the same number of patients as DMD ... that makes the potential number of patients Ezutromid might help (in very approx terms) 15 times that of Sarepta's Eteplirsen. | hugus maximus | |
09/11/2016 16:11 | Don't understand those traders! SRPT is up over 9% and Summit is down 6% today. I understand why Sarepta is up on the 'No Clinton' thing but Summit should be up too? This makes no sense especially as Sarepta describe the Summit deal as a competing product acquisition. Sarepta is valued 20x more than Summit. So I guess we can assume we will get a 20x increase on the news that Utrophin upregulation works? I would expect that we should get some increase towards that in anticipation though... everything so far indicates that it does work. GLA | freemoney1 | |
09/11/2016 10:07 | Yes agree, no Clinton = positive for healthcare. Just need RDZ to Trump FDX in the trial results now. GLA | freemoney1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions